510(k) Report

510(k) · Cleared

Cleared

Polymed Therapeutics Fastep Dipstick Drugs of Abuse Screen Device and Dipcard Drugs of Abuse Screen Device

K121065510(k) TraditionalCleared May 24, 2013413-day reviewClass II21 CFR 862.3100

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Polymed Therapeutics, Inc. · DKZ Enzyme Immunoassay, Amphetamine

Cleared on May 24, 2013 as substantially equivalent to K011673 (ACON Laboratories, Inc., 2001) and 6 other predicates after a 413-day review. Its family tree reaches back 2 generations to 1995.

Decided
May 24, 2013
Review
413 days
Class
Class II
Product code
DKZ
Recalls
None
Predicates
7

Its longest line of descent runs back 2 generations to K945610 (1995). 10 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2002: 1 other ancestor2001: 5 other ancestors1999: 1 other ancestor1996: 1 other ancestorK945610 · Abusign (TM) Amp, Doa-Amp, Accusign (TM) Amp-Doa-Amp, Biosign (TM) Amp, Doa-Amp · Princeton BioMeditech Corp. · 1995K011673 · Acon Amp One Step Amphetamine Test Strip, Acon Amp One Step Amphetamine Test Device · ACON Laboratories, Inc. · 200119952000200520102015
  1. Root · 2 generations backK945610 Abusign (TM) Amp, Doa-Amp, Accusign (TM) Amp-Doa-Amp, Biosign (TM)…Princeton BioMeditech Corp. · 1995
  2. 1 generation backK011673 Acon Amp One Step Amphetamine Test Strip, Acon Amp One Step…ACON Laboratories, Inc. · 2001
  3. This deviceK121065 Polymed Therapeutics Fastep Dipstick Drugs of Abuse Screen Device…Polymed Therapeutics, Inc. · 2013
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K945610Abusign (TM) Amp, Doa-Amp, Accusign (TM) Amp-Doa-Amp, Biosign (TM) Amp, Doa-AmpPrinceton BioMeditech Corp.1995—
−1K011673Acon Amp One Step Amphetamine Test Strip, Acon Amp One Step Amphetamine Test…ACON Laboratories, Inc.2001—
0 (this device)K121065Polymed Therapeutics Fastep Dipstick Drugs of Abuse Screen Device and Dipcard…Polymed Therapeutics, Inc.2013—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199610
199910
200150
200210
FIG. 1 — Lineage of K121065, 1995–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DKZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DKZ device

  1. #1 K233019 AllTest Multi-Drug Rapid Test Cup; AllTest…score 14.6 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (7)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K011673Acon Amp One Step Amphetamine Test Strip, Acon Amp One Step Amphetamine Test DeviceACON Laboratories, Inc.2001—
*K012300Acon Bzo One Step Benzodiazepines Test Strip; Acon Bzo One Step Benzodiazepines Test…
Summary page 2
…ce with the GC/MS and/or LC/MS confirmed clinical urine specimfens. 510(k) numbers for predicate devices are: Amphetamine kOl 11673 Benrodiazepine k012300 Cocaine k010841 MDMA k022589 Morphine 2000 k011353 PCP k011730 T…
ACON Laboratories, Inc.2001—
*K010841Acon Coc One Step Cocaine Test Strip, Acon Coc One Step Cocaine Test Device
Summary page 2
…onfirmed clinical urine specimfens. 510(k) numbers for predicate devices are: Amphetamine kOl 11673 Benrodiazepine k012300 Cocaine k010841 MDMA k022589 Morphine 2000 k011353 PCP k011730 TH-C k003557…
ACON Laboratories, Inc.2001—
*K022589Acon Mdma One Step Ecstasy Test Strip & Acon Mdma One Step Ecstasy Test Device
Summary page 2
…ns. 510(k) numbers for predicate devices are: Amphetamine kOl 11673 Benrodiazepine k012300 Cocaine k010841 MDMA k022589 Morphine 2000 k011353 PCP k011730 TH-C k003557…
ACON Laboratories, Inc.2002—
*K011353Acon Opi One Step Opiates Test Strip, Acon Opi One Step Opiates Test Device
Summary page 2
…e devices are: Amphetamine kOl 11673 Benrodiazepine k012300 Cocaine k010841 MDMA k022589 Morphine 2000 k011353 PCP k011730 TH-C k003557…
ACON Laboratories, Inc.2001—
*K011730Acon PCP One-Step Phencyclidine Test Strip, Acon PCP One-Step Phencyclidine Test Device
Summary page 2
…kOl 11673 Benrodiazepine k012300 Cocaine k010841 MDMA k022589 Morphine 2000 k011353 PCP k011730 TH-C k003557…
ACON Laboratories, Inc.2001—
*K003557Acon THC One Step Marijuana Test Strip (Urine);Acon THC One Step Marijuana Test Device…
Summary page 2
…k012300 Cocaine k010841 MDMA k022589 Morphine 2000 k011353 PCP k011730 TH-C k003557 2…
ACON Laboratories, Inc.2001—

Also cleared against K011673: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 18 years and passes through 3 companies; a new generation was cleared every 11.8 years on median.
  • None of the 10 ancestors has a recall.
  • 3 other devices also cite its predicate K011673.

How does its category compare?

All DKZ devices

DKZ Enzyme Immunoassay, Amphetamine: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.

FDA decisions per year · DKZ

1in 2024

2008: 22009: 22010: 42011: 62012: 52013: 82014: 82015: 52016: 52018: 32019: 32020: 12023: 22024: 1
2007high 8 (2013) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DKZ

180in 2019

2010: 233 days median2011: 123 days median2012: 55 days median2013: 103 days median2014: 128 days median2015: 107 days median2016: 215 days median2018: 128 days median2019: 180 days median
2007high 233 (2010) · low 55 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DKZ

1in 2017

2007: 12008: 32009: 52011: 42013: 12014: 32017: 1
2007high 5 (2009) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DKZ

2in 2025

2008: 122009: 12010: 12011: 22013: 12014: 92015: 82016: 82021: 32022: 42023: 72024: 12025: 2
2007high 12 (2008) · low 0 (2007)2025

MAUDE reports naming product code DKZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—10
20082—312
20092—51
2010423301
2011612342
201255500
2013810311
2014812839
2015510708
2016521508
20170—10
2018312800
2019318000
20201—00
20210—03
20220—04
20232—07
20241—01
20250—02
20260—0—

What is it indicated for?

Polymed Therapeutics Fastep Dipstick Drugs of Abuse Screen Device and Polymed Therapeutics Fastep Dipcard Drugs of Abuse Screen Device are rapid chromatographic immunoassays for the qualitative and simultaneous detection of one to seven of the following drugs in a variety of combinations in human urine. The cutoff concentrations and direct calibrator for these drugs are as follows: Analyte Abbreviation Direct Calibrator Cutoff (ng/mL) Amphetamine AMP…

Read the full statement (166 words)

Polymed Therapeutics Fastep Dipstick Drugs of Abuse Screen Device and Polymed Therapeutics Fastep Dipcard Drugs of Abuse Screen Device are rapid chromatographic immunoassays for the qualitative and simultaneous detection of one to seven of the following drugs in a variety of combinations in human urine. The cutoff concentrations and direct calibrator for these drugs are as follows:

Analyte Abbreviation Direct Calibrator Cutoff (ng/mL)

Amphetamine AMP Amphetamine 1000

Benzodiazepines BZO Oxazepam 300

Cocaine COC Benzoylecgonine 300

Marijuana THC I I -nor-A9-THC9-COOH 50

Morphine MOR Morphine 2000

Phencyclidine PCP Phencyclidine 25

Ecstasy MDMA .3,4-Methylenediioxy-MET 500

For prescription use in central laboratories only. This assay provides only a preliminary analytical test result. A more specific alternative chemical method must be used in order to obtain a confirmred analytical result. Gas Chromatography / Mass Spectrometry (GC/MS) or Liquid Chromatography / Mass Spectrometry (LC/MS) are the preferred confirmatory method.

Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K121065: Polymed Therapeutics Fastep Dipstick Drugs of Abuse Screen Device and Dipcard Drugs of Abuse Screen Device.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K121065

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026